Delisting risk
AEON Biopharma
Develops a therapeutic Botox biosimilar candidate for broad-label use.
$0.3031
After-hours close−0.01 (−1.85%)
At close$0.3088(+5.07%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 6.43%Insiders —
Shares outstanding 44.16M · Float 12.10M · 27.4% free float
Insiders — no current Form 4 position.
Institutions13F, as of Mar 31, 2026
24 holders · 2.84M shares · 9 new positions · 13 increased · 2 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Dauntless Investment Group, LLC | 2.53M | 5.72% | +395.9K | May 14, 2026 |
| Vanguard Capital Management LLC | 90.5K | 0.21% | +90.5Knew | May 15, 2026 |
| Geode Capital Management, LLC | 87.1K | 0.20% | +26.9K | May 15, 2026 |
| Blue Owl Capital Holdings LP | 42.4K | 0.10% | −1.0K | May 14, 2026 |
| XTX Topco Ltd | 20.4K | 0.05% | −36.4K | May 15, 2026 |
| Formidable Asset Management, LLC | 20.0K | 0.05% | +20.0Knew | Apr 22, 2026 |
| Jane Street Group, LLC | 16.4K | 0.04% | +16.4K | May 12, 2026 |
| Vanguard Fiduciary Trust Co | 14.7K | 0.03% | +14.7Knew | May 8, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | Filed |
|---|---|---|---|
| Lynch Timothy P | 10 percent owner | 6.50M | Aug 21, 2026 |
1 ten-percent owner holds 6.50M shares by Form 4, outside the officers-and-directors figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Timothy P. Lynch10 percent owner | Purchase | 1,150,000 | $0.2117 | 6,500,000 |
CongressHouse and Senate disclosures
Not reported.